Sequence of early vascular events after photodynamic therapy.
about
One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue.Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.Management of metastatic carcinoma of the uveal tract: an evidence-based analysis.Confocal scanning laser tomography analysis of choroidal neovascularization and correlation with quantitative fluorescein angiography.Effects of photodynamic therapy on subfoveal blood flow in neovascular age-related macular degeneration patients.Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration.Long-term follow-up of choroidal neovascularization secondary to angioid streaks: case series and literature reviewEffects of smoking on visual acuity of central serous chorioretinopathy patients.Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical TrialDifferent transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranesMatrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular DegenerationSevere decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy.Combination of photodynamic therapy and immunomodulation: current status and future trendsInitial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.Radiation treatment for age-related macular degeneration.Genetic predictors of response to photodynamictherapy.Mechanism of inflammation in age-related macular degenerationReactive macular edema and acute visual loss after photodynamic therapy on the same day of fluorescein angiography.Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells.Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinoloneChanges of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.Combination treatment of low fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane secondary to angioid streaks in Paget's disease - 12 month results.Microvascular hyperpermeability and thrombosis induced by light/dye treatment.Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD.Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.The effect of photodynamic therapy on retrobulbar blood flow parameters.Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms.Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports
P2860
Q31092005-024DE9EC-EAD0-4006-BDA0-6F3BECEDA04AQ33208055-6E75192F-99D5-4F2C-BEF9-0884BD852902Q33287060-7F8C4B12-4195-4614-B5E5-C7B287E10B7EQ33296064-DF711E08-D85E-4744-AAC8-1582F4F6F3C6Q33431311-354E824C-A5AB-43ED-B518-161EADE7D2C5Q33471349-C80DA68B-0991-4CF3-85B7-73E67FEABD87Q34188239-DBAF47A2-1055-41A0-94B0-F463E6B733EDQ34357657-11C111D4-4E2C-4D7D-8927-27E59DDE5E48Q34809984-90798A66-B50F-4B70-8D73-BCDB71077A49Q35087032-92E7CB8F-4331-4832-88FD-9686B398447AQ35762763-F6B3B93C-D657-4225-815A-570C5E11B011Q35762984-582C92CC-0C4B-4495-8543-0E2CEDEE5104Q35954001-064B705A-66FE-4AAF-B49E-1D6C8E7EDD39Q36088747-660DCE17-450B-4CB3-BBE2-2E4C830DAC08Q36516474-072F2CA2-458B-44A5-AA98-D5914585FE0DQ36922722-9142364E-12BB-4DF6-B206-F0EF749BD947Q37053909-7CD6469C-1CF2-4E28-B8B7-02DB62DA3C6EQ37356525-E07384BC-3740-49CD-BBE6-42A86463A234Q37879163-185743DA-532A-48AF-B58C-02867EB3D3D5Q37931236-24CE7BC6-23D0-4CDE-AB98-5599C475EE62Q38064846-11C5B834-A27D-43AA-9506-A96BFB6D7A2FQ38254234-589D9F55-EEC8-4452-9333-0B821FCB2467Q39332109-925593CC-917A-44EB-BA9B-553D35485766Q41350550-346D5413-7EB7-4CC1-81F1-17D6F07E3E86Q41484477-EF7F3519-F79E-4360-83D4-5740D9B14D74Q41914865-ED7F2B3C-583D-4EB9-B6AE-F09477E579B0Q44597849-6CDD3C99-44F4-4D25-924B-2BADE390E42BQ46415542-827F3916-7AB2-42E9-9D60-DA0368365AD7Q46601398-46484BFE-0F7D-4CCE-ADDB-A6ABC58269B5Q46812060-1CFC8389-AAA7-424C-88A8-0B49FEE6CD83Q47978328-FC4D18B6-1E0B-4247-94D7-268C506851B7Q58613700-CA93FCCE-A3DF-4C4F-9758-AE4C61E115C5
P2860
Sequence of early vascular events after photodynamic therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sequence of early vascular events after photodynamic therapy.
@ast
Sequence of early vascular events after photodynamic therapy.
@en
type
label
Sequence of early vascular events after photodynamic therapy.
@ast
Sequence of early vascular events after photodynamic therapy.
@en
prefLabel
Sequence of early vascular events after photodynamic therapy.
@ast
Sequence of early vascular events after photodynamic therapy.
@en
P356
P1476
Sequence of early vascular events after photodynamic therapy.
@en
P2093
Stephan Michels
P304
P356
10.1167/IOVS.02-0604
P407
P577
2003-05-01T00:00:00Z